Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Global Cord Blood ( (CORBF) ) is now available.
On September 1, 2025, the joint provisional liquidators (JPLs) of Global Cord Blood Corporation submitted their thirteenth report to the Grand Court of the Cayman Islands. This report marks a continuation of the company’s ongoing provisional liquidation process, which began on September 22, 2022. The release of this report may have implications for stakeholders, as it provides insights into the company’s current financial status and the progress of its restructuring efforts.
More about Global Cord Blood
Global Cord Blood Corporation is a company operating in the healthcare industry, primarily focused on the collection, storage, and research of umbilical cord blood stem cells. The company serves a significant role in the medical and biotechnology fields, providing services that are crucial for regenerative medicine and various therapeutic applications.
Average Trading Volume: 12,113
Technical Sentiment Signal: Sell
Current Market Cap: $140.6M
For detailed information about CORBF stock, go to TipRanks’ Stock Analysis page.